Skip to menu Skip to content Skip to footer

2019

Journal Article

Reducing post-caesarean delivery surgical site infections: a narrative review

Douville, S. E., Callaway, L. K., Amoako, A., Roberts, J. and Eley, V. A. (2019). Reducing post-caesarean delivery surgical site infections: a narrative review. International Journal of Obstetric Anesthesia, 42, 76-86. doi: 10.1016/j.ijoa.2019.08.007

Reducing post-caesarean delivery surgical site infections: a narrative review

2019

Journal Article

Population pharmacokinetics of periarticular ketorolac in adult patients undergoing total hip or total knee replacement surgery

Gurunathan, Usha, Parker, Suzanne L., Maguire, Richard, Ramdath, Dale, Bijoor, Manu, Wallis, Steven C. and Roberts, Jason A. (2019). Population pharmacokinetics of periarticular ketorolac in adult patients undergoing total hip or total knee replacement surgery. Anesthesia and Analgesia, 129 (3), 701-708. doi: 10.1213/ANE.0000000000003377

Population pharmacokinetics of periarticular ketorolac in adult patients undergoing total hip or total knee replacement surgery

2019

Journal Article

Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients (vol 51, pg 594, 2018)

Dhaese, Sofie A. M., Roberts, Jason A., Carlier, Mieke, Verstraete, Alain G., Stove, Veronique and De Waele, Jan J. (2019). Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients (vol 51, pg 594, 2018). International Journal of Antimicrobial Agents, 54 (3), 380-380. doi: 10.1016/j.ijantimicag.2019.07.022

Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients (vol 51, pg 594, 2018)

2019

Journal Article

Vancomycin population pharmacokinetics in critically ill adults during sustained low-efficiency dialysis

Kanji, Salmaan, Roberts, Jason A., Xie, Jiao, Zelenitsky, Sheryl, Hiremath, Swapnil, Zhang, Guijun, Watpool, Irene, Porteous, Rebecca and Patel, Rakesh (2019). Vancomycin population pharmacokinetics in critically ill adults during sustained low-efficiency dialysis. Clinical Pharmacokinetics, 59 (3), 327-334. doi: 10.1007/s40262-019-00817-6

Vancomycin population pharmacokinetics in critically ill adults during sustained low-efficiency dialysis

2019

Journal Article

Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: a prospective observational study

Dhaese, Sofie A.M., Thooft, Alexander D.J., Farkas, Andras, Lipman, Jeffrey, Verstraete, Alain G., Stove, Veronique, Roberts, Jason A. and De Waele, Jan J. (2019). Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: a prospective observational study. Journal of Critical Care, 52, 75-79. doi: 10.1016/j.jcrc.2019.04.013

Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: a prospective observational study

2019

Journal Article

Augmented renal clearance: A real phenomenon with an uncertain cause

Baptista, João Pedro, Roberts, Jason A. and Udy, Andrew A. (2019). Augmented renal clearance: A real phenomenon with an uncertain cause. Anaesthesia Critical Care and Pain Medicine, 38 (4), 335-336. doi: 10.1016/j.accpm.2019.03.002

Augmented renal clearance: A real phenomenon with an uncertain cause

2019

Journal Article

In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration

T.P. Wan, Winnie, Guerra Valero, Yarmarly, Choi, Gordon Y.S., Ordóñez Mejia, Jenny L., Wallis, Steven C., Joynt, Gavin M., Lipman, Jeffrey, Gomersall, Charles D. and Roberts, Jason A. (2019). In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration. International Journal of Antimicrobial Agents, 54 (2), 261-264. doi: 10.1016/j.ijantimicag.2019.03.018

In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration

2019

Journal Article

Corrigendum to ‘Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients’ (International Journal of Antimicrobial Agents (2018) 51(4) (594–600), (S0924857917304491), (10.1016/j.ijantimicag.2017.12.015))

Dhaese, Sofie A.M., Roberts, Jason A., Carlier, M., Verstraete, Alain G., Stove, Veronique and DeWaele, J. J. (2019). Corrigendum to ‘Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients’ (International Journal of Antimicrobial Agents (2018) 51(4) (594–600), (S0924857917304491), (10.1016/j.ijantimicag.2017.12.015)). International Journal of Antimicrobial Agents, 54 (2), 271-271. doi: 10.1016/j.ijantimicag.2019.07.007

Corrigendum to ‘Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients’ (International Journal of Antimicrobial Agents (2018) 51(4) (594–600), (S0924857917304491), (10.1016/j.ijantimicag.2017.12.015))

2019

Journal Article

Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction

Sime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2019). Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction. Antimicrobial Agents and Chemotherapy, 63 (10) e01265-19. doi: 10.1128/aac.01265-19

Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction

2019

Journal Article

What antibiotic exposures are required to suppress the emergence of resistance for gram‑negative bacteria? A systematic review

Sumi, Chandra Datta, Heffernan, Aaron J., Lipman, Jeffery, Roberts, Jason A. and Sime, Fekade B. (2019). What antibiotic exposures are required to suppress the emergence of resistance for gram‑negative bacteria? A systematic review. Clinical Pharmacokinetics, 58 (11), 1407-1443. doi: 10.1007/s40262-019-00791-z

What antibiotic exposures are required to suppress the emergence of resistance for gram‑negative bacteria? A systematic review

2019

Journal Article

Pharmacokinetics of benzylpenicillin (penicillin G) during prolonged intermittent renal replacement therapy

Cheng, Vesa, Rawlins, Matthew, Chang, Tim, Fox, Emma, Dyer, John, Allen, Chris, Litton, Edward, Page, Michael M., Hoad, Kirsten and Roberts, Jason A. (2019). Pharmacokinetics of benzylpenicillin (penicillin G) during prolonged intermittent renal replacement therapy. Chemotherapy, 64 (1), 1-5. doi: 10.1159/000499375

Pharmacokinetics of benzylpenicillin (penicillin G) during prolonged intermittent renal replacement therapy

2019

Journal Article

Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration

Economou, Caleb J. P., Xie, Jiao, Comadira, Gregory, Richards, Brent, Tallott, Mandy, Wallis, Steven C., Ordoñez, Jenny, Lipman, Jeffrey and Roberts, Jason A. (2019). Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration. International Journal of Antimicrobial Agents, 54 (3), 351-355. doi: 10.1016/j.ijantimicag.2019.06.027

Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration

2019

Journal Article

Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia

Weber, Nicholas, Jackson, Kathryn, McWhinney, Brett, Ungerer, Jacobus, Kennedy, Glen, Lipman, Jeffrey and Roberts, Jason A. (2019). Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia. Journal of Infection and Chemotherapy, 25 (7), 503-508. doi: 10.1016/j.jiac.2019.02.014

Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia

2019

Journal Article

Implementasi Antimicrobial Stewardship Program di Kawasan Asia: Sebuah Kajian Sistematis

Setiawan, Eko, Wibowo, Yosi I., Setiadi, Adji P., Nurpatria, Yul'aini, Sosilya, Hernycane, Wardhani, Dian K., Cotta, Menino O., Abdul-Aziz, Mohd-Hafiz and Roberts, Jason (2019). Implementasi Antimicrobial Stewardship Program di Kawasan Asia: Sebuah Kajian Sistematis. Indonesian Journal of Clinical Pharmacy, 8 (2), 141-156. doi: 10.15416/ijcp.2019.8.2.141

Implementasi Antimicrobial Stewardship Program di Kawasan Asia: Sebuah Kajian Sistematis

2019

Journal Article

Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial

Hagel, Stefan, Fiedler, Sandra, Hohn, Andreas, Brinkmann, Alexander, Frey, Otto R., Hoyer, Heike, Schlattmann, Peter, Kiehntopf, Michael, Roberts, Jason A., Pletz, Mathias W., Bloos, Frank, Angermair, Stefan, Bracht, Hendrik, Barth, Eberhard, Kluge, Stefan, Nierhaus, Axel, Motsch, Johann, Brenner, Thorsten, Annecke, Thorsten, Bach, Friedhelm, Weigand, Markus, Schappacher, Markus, Von Ameln-Mayerhofer, Andreas, Michels, Guido, Roehr, Anka, Fuchs, Thomas, Eichner, Sarah, Köng, Christina, Pinder, Nadine ... Braune, Anke (2019). Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial. Trials, 20 (1) 330, 330. doi: 10.1186/s13063-019-3437-x

Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial

2019

Journal Article

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients

Sime, Fekade B., Byrn, Catherine J., Parker, Suzanne, Stuart, Janine, Butler, Jenie, Starr, Therese, Pandey, Saurabh, Wallis, Steven C., Lipman, Jeffery and Roberts, Jason A. (2019). Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients. Critical Care, 23 (1) 205, 205. doi: 10.1186/s13054-019-2483-9

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients

2019

Journal Article

Nebulized tranexamic acid therapy for hemoptysis associated with submassive pulmonary embolism

Dhanani, Jayesh A., Roberts, Jason and Reade, Michael C (2019). Nebulized tranexamic acid therapy for hemoptysis associated with submassive pulmonary embolism. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 32 (1) jamp.2019.1534, 12-14. doi: 10.1089/jamp.2019.1534

Nebulized tranexamic acid therapy for hemoptysis associated with submassive pulmonary embolism

2019

Journal Article

Defining optimal dosing of ciprofloxacin in patients with septic shock

Roberts, Jason A., Alobaid, Abdulaziz S., Wallis, Steven C., Perner, Anders, Lipman, Jeffrey and Sjövall, Fredrik (2019). Defining optimal dosing of ciprofloxacin in patients with septic shock. Journal of Antimicrobial Chemotherapy, 74 (6) dkz069, 1662-1669. doi: 10.1093/jac/dkz069

Defining optimal dosing of ciprofloxacin in patients with septic shock

2019

Journal Article

Obesity in the critically ill: a narrative review

Schetz, Miet, De Jong, Audrey, Deane, Adam M., Druml, Wilfried, Hemelaar, Pleun, Pelosi, Paolo, Pickkers, Peter, Reintam-Blaser, Annika, Roberts, Jason, Sakr, Yasser and Jaber, Samir (2019). Obesity in the critically ill: a narrative review. Intensive Care Medicine, 45 (6), 757-769. doi: 10.1007/s00134-019-05594-1

Obesity in the critically ill: a narrative review

2019

Journal Article

Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?

Heffernan, A. J., Germano, A., Sime, F. B., Roberts, Jason A. and Kimura, E. (2019). Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?. European Journal of Clinical Pharmacology, 75 (9), 1219-1226. doi: 10.1007/s00228-019-02694-1

Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?